Skip to main navigation Skip to search Skip to main content

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories.

  • Yapeng Su
  • , Daniel Chen
  • , Christopher Lausted
  • , Dan Yuan
  • , Jongchan Choi
  • , Cheng Dai
  • , Valentin Voillet
  • , Kelsey Scherler
  • , Pamela Troisch
  • , Duvvuri Venkata R
  • , Priyanka Baloni
  • , Guangrong Qin
  • , Brett Smith
  • , Sergey Kornilov
  • , Clifford Rostomily
  • , Alex Xu
  • , Jing Li
  • , Shen Dong
  • , Alissa Rothchild
  • , Jing Zhou
  • Kim Murray, Rick Edmark, Sunga Hong, Lesley Jones, Yong Zhou, Ryan Roper, Sean Mackay, O'Mahony D Shane, Christopher Dale, Wallick Julie A, Algren Heather A, Michael Zager A, Magis Andrew T, Wei Wei, Price Nathan D, Sui Huang, Naeha Subramanian, Kai Wang, Jennifer Hadlock, Leroy Hood, Alan Aderem, Bluestone Jeffrey A, Lanier Lewis L, Phil Greenberg, Raphael Gottardo, Davis Mark M, Goldman Jason D, Heath James R, ISB-Swedish COVID19 Biobanking Unit

Research output: Contribution to journalArticle

Abstract

Host immune responses play central roles in controlling SARS-CoV2 infection, yet remain incompletely characterized and understood. Here, we present a comprehensive immune response map spanning 454 proteins and 847 metabolites in plasma integrated with single-cell multi-omic assays of PBMCs in which whole transcriptome, 192 surface proteins, and T and B cell receptor sequence were co-analyzed within the context of clinical measures from 50 COVID19 patient samples. Our study reveals novel cellular subpopulations, such as proliferative exhausted CD8 + and CD4 + T cells, and cytotoxic CD4 + T cells, that may be features of severe COVID-19 infection. We condensed over 1 million immune features into a single immune response axis that independently aligns with many clinical features and is also strongly associated with disease severity. Our study represents an important resource towards understanding the heterogeneous immune responses of COVID-19 patients and may provide key information for informing therapeutic development.

Original languageUndefined/Unknown
JournalArticles, Abstracts, and Reports
StatePublished - Jul 31 2020

Cite this